feed,title,long_url,short_url
Barron's,"Moderna’s Vaccine Will Likely Be Approved, Analyst Says. Why the Stock Is ‘Unattractive.’",https://www.barrons.com/articles/moderna-stock-is-unattractive-despite-despite-vaccines-chances-51595512726?mod=RTA,https://j.mp/2WMeMig
